Document is current

Article History

First Online: 6 December 2025

Declarations

:

: Peter Whelan: confirms that he has no competing interests. Kirsty Balachandran: honoraria/speaker fees: Bayer, Bristol Myers Squibb, Merck and Servier, and travel grants: GSK. Kenrick Ng: speaker fees/honoraria: Bayer, Pfizer, Astra Zeneca, UCB Rheumatology and Janssen Pharmaceuticals; travel: Bayer; and research grants: prostate cancer research. Editor-in-Chief position: Kenrick Ng is an editor-in-chief of Oncology and Therapy . Kenrick Ng was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

: Lydia Alborn, managing Editor of  Oncology and Therapy , assisted with the recording and editing of the podcast audio, and provided English language editing of the transcript for clarity. The initial podcast recording was transcribed by artificial intelligence (AI), and the final transcript underwent human editing for accuracy and quality assurance purposes.